New experimental drugs developed by researchers can help reduce some of the dangerous side effects caused by diabetes medicine. Initially, tests on animals suggest that novel combination treatment is safe and effective in regulating blood sugar levels in type 2 diabetes.
For your information, let us tell you that Rosiglitazone was first approved for human use by the FDA in 1999. It was certainly effective as a treatment for type 2 diabetes patients, although some side effects caused concerns in addition to several adverse effects. Which include side effects like heart attack, osteoporosis, weight gain.
Also by 2010 it was clear that rosiglitazone was in trouble. Drug-maker GlaxoSmithKline faced several civil lawsuits, and was eventually convicted by the US government of withdrawing study data that suggested the drug may increase the risk of heart attack. Since then, the drug has been withdrawn from many international markets, although it is still available for use in the United States.